CochLear Ltd. Unsponsored ADR (OTCMKTS:CHEOY) Stock Now Rated “Hold” by Sell-Side Brokerages

CochLear Ltd. Unsponsored ADR (OTCMKTS:CHEOY) has been given a consensus recommendation of “Hold” by the five research firms that are presently covering the company, Marketbeat.com reports. Five investment analysts have rated the stock with a hold recommendation. The average 1-year price objective among analysts that have issued a report on the stock in the last year is $117.00.

A number of equities research analysts have recently commented on CHEOY shares. Canaccord Genuity Group cut shares of CochLear from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, August 18th. Jefferies Financial Group downgraded shares of CochLear from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, July 22nd. Finally, Royal Bank Of Canada lowered shares of CochLear from an “outperform” rating to a “sector perform” rating and set a $117.00 price target on the stock. in a research report on Thursday, July 16th.

CochLear Stock Up 6.0%

Shares of CHEOY opened at $53.09 on Friday. CochLear has a 52-week low of $31.82 and a 52-week high of $98.29. The firm’s fifty day moving average is $48.22 and its two-hundred day moving average is $52.01.

CochLear Company Profile

Cochlear Limited is an Australian medical device company that develops, manufactures and supplies implantable hearing solutions for people with moderate to profound hearing loss. Its portfolio includes cochlear implants, bone conduction implants and related sound processors, accessories and connectivity products designed to help users hear in a range of environments.

The company also provides clinical support, rehabilitation resources, software, technical services and ongoing care for recipients, clinicians and hearing professionals.